- Home
- Publications
- Publication Search
- Publication Details
Title
Personalized Medicine: Four Perspectives of Tailored Medicine
Authors
Keywords
-
Journal
Statistics in Biopharmaceutical Research
Volume 7, Issue 3, Pages 214-229
Publisher
Informa UK Limited
Online
2015-07-09
DOI
10.1080/19466315.2015.1059354
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A regression tree approach to identifying subgroups with differential treatment effects
- (2015) Wei-Yin Loh et al. STATISTICS IN MEDICINE
- A Bayesian Approach to Subgroup Identification
- (2014) James O. Berger et al. Journal of Biopharmaceutical Statistics
- Subgroups: Time to Go Back to Basic Statistical Principles?
- (2014) Oliver N. Keene et al. Journal of Biopharmaceutical Statistics
- Strategies for Identifying Predictive Biomarkers and Subgroups with Enhanced Treatment Effect in Clinical Trials Using SIDES
- (2014) Ilya Lipkovich et al. Journal of Biopharmaceutical Statistics
- Adaptive Designs for Confirmatory Clinical Trials with Subgroup Selection
- (2014) Nigel Stallard et al. Journal of Biopharmaceutical Statistics
- Identifying a Subpopulation for a Tailored Therapy: Bridging Clinical Efficacy From a Laboratory-Developed Assay to a Validated In Vitro Diagnostic Test Kit
- (2014) Jonathan S. Denne et al. Statistics in Biopharmaceutical Research
- A review of phase II trial designs for initial marker validation
- (2013) Sumithra J. Mandrekar et al. Contemporary Clinical Trials
- A framework for the analysis of heterogeneity of treatment effect in patient-centered outcomes research
- (2013) Ravi Varadhan et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Qualitative interaction trees: a tool to identify qualitative treatment-subgroup interactions
- (2013) Elise Dusseldorp et al. STATISTICS IN MEDICINE
- Multiplicity Issues in Clinical Trials With Multiple Objectives
- (2013) Mohammad F. Huque et al. Statistics in Biopharmaceutical Research
- A Statistical Framework for Decision Making in Confirmatory Multipopulation Tailoring Clinical Trials
- (2012) Brian A. Millen et al. DRUG INFORMATION JOURNAL
- Estimating Individualized Treatment Rules Using Outcome Weighted Learning
- (2012) Yingqi Zhao et al. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION
- Variable Selection for Qualitative Interactions in Personalized Medicine While Controlling the Family-Wise Error Rate
- (2011) Lacey Gunter et al. Journal of Biopharmaceutical Statistics
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Subgroup identification from randomized clinical trial data
- (2011) Jared C. Foster et al. STATISTICS IN MEDICINE
- The HER2 testing conundrum
- (2010) Malorye Allison NATURE BIOTECHNOLOGY
- The Path to Personalized Medicine
- (2010) Margaret A. Hamburg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pemetrexed in the treatment of advanced non-squamous lung cancer
- (2009) Antonio Rossi et al. LUNG CANCER
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
- (2009) Eric Van Cutsem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Approval Summary: Pemetrexed in the Initial Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer
- (2009) M. H. Cohen et al. ONCOLOGIST
- Prognostic versus predictive value of biomarkers in oncology
- (2008) C.N.A.M. Oldenhuis et al. EUROPEAN JOURNAL OF CANCER
- Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
- (2008) Carsten Bokemeyer et al. JOURNAL OF CLINICAL ONCOLOGY
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started